DoW Lupus, Impact Award

The DoW Lupus, Impact Award is a funding mechanism that supports high-risk/high-reward research in lupus research and/or lupus disease. The emphasis is on impact, and research must address at least one of the fiscal year 2026 Lupus Research Program (LRP) Impact Award (IPA) focus areas. This funding mechanism does not allow clinical trials. • The award encourages, but does not require, preliminary data. • An individual may be named as Principal Investigator (PI) on only one application per LRP award mechanism. • The estimated funding for this award is $5,000,000. • The award is open to unrestricted entities, subject to any clarification in the text field entitled "Additional Information on Eligibility".